| Trial ID: | L4657 |
| Source ID: | NCT00671008
|
| Associated Drug: |
Biphasic Insulin Aspart 30
|
| Title: |
Observational Study of Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 Diabetes
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes|Diabetes Mellitus, Type 1|Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: biphasic insulin aspart 30|DRUG: insulin detemir
|
| Outcome Measures: |
Primary: Glycaemic control as measured by HbA1c, After 24 weeks | Secondary: Percentage of subjects to reach HbA1c below 7.0% and =6.5%, After 24 weeks|Percentage of subjects on once vs twice daily injections of Levemir® or NovoMix® 30, After 24 weeks|The effect on glycamic control as measured by FPG, After 24 weeks|The effect on glycamic control as measured by PG profile, After 24 weeks|Change in body weight, After 24 weeks
|
| Sponsor/Collaborators: |
Sponsor: Novo Nordisk A/S
|
| Gender: |
ALL
|
| Age: |
CHILD, ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
400
|
| Study Type: |
OBSERVATIONAL
|
| Study Designs: |
Observational Model: |Time Perspective: p
|
| Start Date: |
2007-12
|
| Completion Date: |
2008-09
|
| Results First Posted: |
|
| Last Update Posted: |
2024-01-02
|
| Locations: |
Sarajevo, Bosnia and Herzegovina
|
| URL: |
https://clinicaltrials.gov/show/NCT00671008
|
